13th July 2025

By Dr Jacqueline Radley, British Menopause Society Accredited Advanced Menopause Specialist

HRT and Weight Loss Injections: What You Need to Know

New Guidance from the British Menopause Society (BMS)

More women than ever are using weight loss injections such as Ozempic, Wegovy, Zepbound, and Mounjaro. These medications — known as GLP-1 receptor agonists — are commonly used to treat type 2 diabetes, but have also become popular for weight management. They’re safe and effective for many people, including women going through the menopause.

However, if you’re also using HRT (Hormone Replacement Therapy), there’s new guidance from the British Menopause Society that you should be aware of.

What’s the concern?

GLP-1 medications work by slowing down how quickly food leaves the stomach. While this helps with blood sugar and appetite, it can also affect how your body absorbs other medications — including oral progesterone, a key part of HRT.

Oral progesterone (such as Utrogestan) helps to protect the lining of the womb if you are taking oestrogen. If not enough is absorbed, it may not offer full protection, which could increase the risk of endometrial (womb) problems over time.

Summary of the BMS Guidance

The British Menopause Society (April 2025) advises the following:

To ensure the womb lining remains protected, you may be advised to switch to a different type of progesterone, such as:

✔️ A Mirena coil
✔️ A combined oestrogen/progestogen patch
✔️ Vaginal progesterone (off-licence but sometimes used)

What this means for you

This does not mean you have to stop using GLP-1 medications or HRT — both can still be used safely and effectively. But it does mean your treatment plan might need a simple adjustment to keep you well protected.

What should you do next?

👉 Read the full BMS guidance here

Still unsure about HRT and weight loss injections?


We’re here to help you feel confident in your menopause care.
Get expert support – book your appointment today.

Call Now Button